» Articles » PMID: 27799961

Heterozygous Inactivation of the Nuclear Receptor PXR/NR1I2 in a Patient With Anabolic Steroid-Induced Intrahepatic Cholestasis

Overview
Journal Hepat Mon
Publisher Brieflands
Specialty Gastroenterology
Date 2016 Nov 2
PMID 27799961
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The incidence of liver damage due to steroid consumption is increasing due to the omnipresence of the idealized body image and the widespread availability of drugs via the Internet. The genetic factors underlying individual susceptibility are not presently known.

Case Presentation: A male patient developed cholestatic liver injury two weeks after a two-month course of anabolic steroids. Next-generation sequencing (NGS) of 24 cholestasis-related genes revealed a heterozygous two-basepair deletion in exon 1 of the pregnane X receptor gene (PXR). Serum bile salt levels showed marked imbalances, strongly resembling the changes observed in patients with biliary obstruction.

Conclusions: This case of PXR haploinsufficiency reveals transcriptional regulatory functions activated in the liver under xenobiotic stress by steroids, which appear to require two functional copies of the nuclear receptor gene. Deranged bile salt levels outline the central role of PXR in bile acid synthesis, modification, and export.

Citing Articles

Epistane, an anabolic steroid used for recreational purposes, causes cholestasis with elevated levels of cholic acid conjugates, by upregulating bile acid synthesis (CYP8B1) and cross-talking with nuclear receptors in human hepatocytes.

Petrov P, Fernandez-Murga L, Conde I, Martinez-Sena T, Guzman C, Castell J Arch Toxicol. 2020; 94(2):589-607.

PMID: 31894354 DOI: 10.1007/s00204-019-02643-y.


Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors.

Stolz A, Navarro V, Hayashi P, Fontana R, Barnhart H, Gu J Aliment Pharmacol Ther. 2019; 49(9):1195-1204.

PMID: 30934130 PMC: 6682544. DOI: 10.1111/apt.15211.

References
1.
Trottier J, Bialek A, Caron P, Straka R, Milkiewicz P, Barbier O . Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting. PLoS One. 2011; 6(7):e22094. PMC: 3132779. DOI: 10.1371/journal.pone.0022094. View

2.
Gerber P, Kukova G, Meller S, Neumann N, Homey B . The dire consequences of doping. Lancet. 2008; 372(9639):656. DOI: 10.1016/S0140-6736(08)61278-7. View

3.
Bolding G, Sherr L, Elford J . Use of anabolic steroids and associated health risks among gay men attending London gyms. Addiction. 2002; 97(2):195-203. DOI: 10.1046/j.1360-0443.2002.00031.x. View

4.
Brennan B, Kanayama G, Pope Jr H . Performance-enhancing drugs on the web: a growing public-health issue. Am J Addict. 2013; 22(2):158-61. PMC: 3578418. DOI: 10.1111/j.1521-0391.2013.00311.x. View

5.
Rahnema C, Crosnoe L, Kim E . Designer steroids - over-the-counter supplements and their androgenic component: review of an increasing problem. Andrology. 2015; 3(2):150-5. DOI: 10.1111/andr.307. View